Clinical Trials Browser

Interventional × Glioma × cemiplimab × Clear all

NCT04826393 2025-10-22

ASP8374 + Cemiplimab in Recurrent Glioma

Phase 1 Completed

Glioblastoma, Glioma, Lymphoma, Follicular

NCT03690869 2025-04-08

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Phase 1/2 Terminated

57 enrolled 31 charts

Diffuse Intrinsic Pontine Glioma, Glioma, Recurrence, Central Nervous System Neoplasms